Padagis

Padagis Overview

Padagis LLC was formed following the acquisition of Perrigo Company plc's Rx Division by Altaris Capital. Padagis is a leader in the generic prescription pharmaceutical industry and has more than 1,300 employees across six locations in the United States and Israel. The companys diversified portfolio consists of over 200 product families and 800 SKUs, with a focus on extended topical dosage forms, including creams, ointments, lotions, gels, foams, liquids, and nasal sprays. The company has a long track record of launching first-to-file and first-to-market generic pharmaceutical products that have helped to make prescription products more affordable for patients and reduce costs for the healthcare system. Padagis Pharmaceuticals Israel inherited the operations of Perrigo Israel operating a manufacturing facility in Yeruham in the south of Israel.

Latest News

No news articles.

Team Members

1

Employees: 51-200

Web & Social Links

Website	padagis.com/
LinkedIn	LinkedIn

Locations

Yeruham, Israel

Shoham, Israel

United States

Photos & Videos

No files yet

Padagis Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info

Confidence	50/100
Missing	funding stage, product stage, sector, tags, business model, video or image, funding rounds, news, markets, not claimed
BI Verification	Maor Perlov
Creator	Maor Perlov
Creator email	maorperlov@gmail.com
Last updater	Maor Perlov
Updater email	maorperlov@gmail.com
Last update	2021-11-30T00:00:00.000Z
Created	2021-11-30T00:00:00.000Z